Scott Foster, MD
Adult Reconstructive Orthopaedic Surgery · Mansfield, OHNPI 1477719896
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,678 of the $37,716 with a category attached, or 89.3%. Medical Device Business Services, Inc. accounts for 94.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $31,177 and has fallen 99.7% since, to $100 in 2025.
Across 53 payments — averaging $711.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$36K
- Zimmer Biomet$2K
- Orthalign Inc$100
- Johnson & Johnson$68
- Wound Management Technologies, Inc$18
- Amgen$14
- plus $25 from 2 others
What the payments were for
- Consulting fees$33,67889%
- Travel & lodging$2,4847%
- Food & beverage$1,5554%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 39 | $35,674 |
| Zimmer Biomet | 7 | $1,817 |
| Orthalign Inc | 1 | $100 |
| Johnson & Johnson | 2 | $68 |
| Wound Management Technologies, Inc | 1 | $18 |
| Amgen | 1 | $14 |
| AbbVie | 1 | $13 |
| Avanos Medical | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$34,647
- ACTIS$2,268
- Persona$103
- ORTHALIGN PLUS$100
How this compares
$37,716 in reported general payments places this provider in the 70th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 110 | $3,107 |
| Dexamethasone Sodium Phosphate | 49 | $622 |
| Meloxicam | 52 | $130 |
| Amoxicillin | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Mansfield
- Adolph LombardiNew Albany$14.7M
- Ray WasielewskiColumbus$9.6M
- Viktor KrebsCleveland$7.5M
- Keith BerendNew Albany$4.6M
- Nicolas PiuzziCleveland$1.2M
- Michael BloomfieldCleveland$321K
- Matthew BealColumbus$319K
- Jason HurstNew Albany$255K
- Michael MorrisNew Albany$252K
- Trevor MurrayCleveland$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.